Literature DB >> 1674737

Development of Francisella tularensis antigen responses measured as T-lymphocyte proliferation and cytokine production (tumor necrosis factor alpha, gamma interferon, and interleukin-2 and -4) during human tularemia.

H M Surcel1, H Syrjälä, R Karttunen, S Tapaninaho, E Herva.   

Abstract

The lymphocyte immune reactivity of 12 tularemia patients to Francisella tularensis antigens prepared from the bacterial cell envelope was examined during a 14-week follow-up study. Lymphocyte blast transformation responses of peripheral blood mononuclear cells (PBMC) to different protein antigens appeared simultaneously 2 weeks after the first symptoms of tularemia, indicating that none of these antigens had any special role at the early phase of immunization. While the lymphocyte blast transformation responses of total lymphocytes to all bacterial antigens were negative in the week 1 samples, continuously growing F. tularensis-specific T-lymphocyte lines were obtained from PBMC at the same time, indicating that an immune response had already occurred. Later, the T-lymphocyte lines and lymphocyte blast transformation responses were similar. Lymphocyte activation among the PBMC was reflected in an increased number of HLA-DR antigen-expressing, CD4-positive T lymphocytes (CD4+ DR+). The mean secretion of soluble CD8 from F. tularemia antigen-stimulated PBMC increased 2 weeks after tularemia onset, but the mean number of CD8+ DR+ T lymphocytes did not vary during the study period and no correlation could be found between the soluble CD8 and number of CD8+ DR+ T lymphocytes. F. tularemia antigen-induced cytokine production was measured from the PBMC supernatants. High levels of tumor necrosis factor alpha were detected from the first week onwards. The highest levels of interleukin-2 and gamma interferon were recorded during the second and third weeks, respectively, after tularemia onset. Interleukin-4 could not be demonstrated in the lymphocyte supernatants.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1674737      PMCID: PMC257948          DOI: 10.1128/iai.59.6.1948-1953.1991

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  25 in total

Review 1.  Heterogeneity of cytokine secretion patterns and functions of helper T cells.

Authors:  T R Mosmann; R L Coffman
Journal:  Adv Immunol       Date:  1989       Impact factor: 3.543

Review 2.  Cachectin/tumour necrosis factor.

Authors:  K J Tracey; H Vlassara; A Cerami
Journal:  Lancet       Date:  1989-05-20       Impact factor: 79.321

3.  Agglutination and ELISA methods in the diagnosis of tularemia in different clinical forms and severities of the disease.

Authors:  H Syrjälä; P Koskela; T Ripatti; A Salminen; E Herva
Journal:  J Infect Dis       Date:  1986-01       Impact factor: 5.226

4.  Diversity of Francisella tularensis antigens recognized by human T lymphocytes.

Authors:  H M Surcel
Journal:  Infect Immun       Date:  1990-08       Impact factor: 3.441

Review 5.  Nature of protective immunity to Francisella tularensis.

Authors:  A Tärnvik
Journal:  Rev Infect Dis       Date:  1989 May-Jun

6.  A whole-blood lymphocyte stimulation test for the diagnosis of human tularemia.

Authors:  H Syrjälä; E Herva; J Ilonen; K Saukkonen; A Salminen
Journal:  J Infect Dis       Date:  1984-12       Impact factor: 5.226

7.  Membrane proteins of Francisella tularensis LVS differ in ability to induce proliferation of lymphocytes from tularemia-vaccinated individuals.

Authors:  H M Surcel; M Sarvas; I M Helander; E Herva
Journal:  Microb Pathog       Date:  1989-12       Impact factor: 3.738

8.  Immunospecific T-lymphocyte stimulation by membrane proteins from Francisella tularensis.

Authors:  G Sandström; A Tärnvik; H Wolf-Watz
Journal:  J Clin Microbiol       Date:  1987-04       Impact factor: 5.948

9.  Immune activation in measles.

Authors:  D E Griffin; B J Ward; E Jauregui; R T Johnson; A Vaisberg
Journal:  N Engl J Med       Date:  1989-06-22       Impact factor: 91.245

Review 10.  The cytokine network.

Authors:  F R Balkwill; F Burke
Journal:  Immunol Today       Date:  1989-09
View more
  13 in total

Review 1.  Francisella tularensis--a model for studies of the immune response to intracellular bacteria in man.

Authors:  A Tärnvik; M Eriksson; G Sandström; A Sjöstedt
Journal:  Immunology       Date:  1992-07       Impact factor: 7.397

2.  Persistence of cell-mediated immunity three decades after vaccination with the live vaccine strain of Francisella tularensis.

Authors:  Kjell Eneslätt; Cecilia Rietz; Patrik Rydén; Svenja Stöven; Robert V House; Lawrence A Wolfraim; Arne Tärnvik; Anders Sjöstedt
Journal:  Eur J Immunol       Date:  2011-02-21       Impact factor: 5.532

Review 3.  Tularemia vaccines.

Authors:  Daniela Putzova; Iva Senitkova; Jiri Stulik
Journal:  Folia Microbiol (Praha)       Date:  2016-05-19       Impact factor: 2.099

4.  Murine T-cell response to native and recombinant protein antigens of Rickettsia tsutsugamushi.

Authors:  C J Hickman; C K Stover; S W Joseph; E V Oaks
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

5.  Generation of heterogeneous memory T cells by live attenuated tularemia vaccine in humans.

Authors:  Rosangela Salerno-Gonçalves; Matthew J Hepburn; Sina Bavari; Marcelo B Sztein
Journal:  Vaccine       Date:  2009-09-30       Impact factor: 3.641

6.  Immunity to Francisella.

Authors:  Siobhán C Cowley; Karen L Elkins
Journal:  Front Microbiol       Date:  2011-02-16       Impact factor: 5.640

7.  Signatures of T cells as correlates of immunity to Francisella tularensis.

Authors:  Kjell Eneslätt; Monica Normark; Rafael Björk; Cecilia Rietz; Carl Zingmark; Lawrence A Wolfraim; Svenja Stöven; Anders Sjöstedt
Journal:  PLoS One       Date:  2012-03-06       Impact factor: 3.240

8.  M-Cells Contribute to the Entry of an Oral Vaccine but Are Not Essential for the Subsequent Induction of Protective Immunity against Francisella tularensis.

Authors:  Aimee L Cunningham; M Neal Guentzel; Jieh-Juen Yu; Chiung-Yu Hung; Thomas G Forsthuber; Christopher S Navara; Hideo Yagita; Ifor R Williams; Karl E Klose; Tonyia D Eaves-Pyles; Bernard P Arulanandam
Journal:  PLoS One       Date:  2016-04-21       Impact factor: 3.240

9.  Microarray analysis of human monocytes infected with Francisella tularensis identifies new targets of host response subversion.

Authors:  Jonathan P Butchar; Thomas J Cremer; Corey D Clay; Mikhail A Gavrilin; Mark D Wewers; Clay B Marsh; Larry S Schlesinger; Susheela Tridandapani
Journal:  PLoS One       Date:  2008-08-13       Impact factor: 3.240

10.  Tularemia vaccine development: paralysis or progress?

Authors:  Raju Sunagar; Sudeep Kumar; Brian J Franz; Edmund J Gosselin
Journal:  Vaccine (Auckl)       Date:  2016-05-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.